Thyrocare Technologies Limited, a active public limited company, was established on 28 January 2000 in Navi Mumbai, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: L85110MH2000PLC123882. Registered under ROC Roc Mumbai. it is listed on BSE: 539871 and NSE: THYROCARE. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹53.05 Cr.
It upholds a compliant status. In 2023, it reported revenue of ₹491.85 Cr and a net worth of ₹521.04 Cr. Employing 1,758 professional, Its leadership includes Nishant Amilal Shah (Director), Harshil Jiten Vora (Director), Anandh Sundar (Director). Past directors included Gopal Shivram Hegde, Vishwas Madhav Kulkarni, Narayanasamy Palanisamy. It holds no open charges and ₹45.05 Cr settled loans. Its latest AGM occurred on 31 July 2025, with the balance sheet filed on 31 March 2025. It is based at D37/1, Ttc Industrial Area, Midc, Turbhe,, Navi Mumbai, Maharashtra, 400703.
L85110MH2000PLC123882
123882
28 January 2000
₹100.00 Cr
₹53.05 Cr
Roc Mumbai
Listed (BSE: 539871, NSE: THYROCARE)
Active
Explore comprehensive insights into Thyrocare Technologies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nishant Amilal Shah | Director | 15 Jun 2024 | Current |
| Harshil Jiten Vora | Director | 14 Jul 2023 | Current |
| Anandh Sundar | Director | 15 Jun 2024 | Current |
| Indumati Gopinathan | Director | 12 Aug 2017 | Current |
| Alok Kumar Jagnani | Additional Director | 24 Jul 2025 | Current |
| Dhaval Rajesh Shah | Director | 06 Oct 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Aug 2024 | Past |
| Pramod Abcsdd | Director | 23 May 2023 | Past |
| Pramod Abcsdd | Director | 19 Sep 2019 | Past |
| Pramod Abcsdd | Company Secretary | 02 Sep 2014 | Past |
| Pramod Abcsdd | Alternate Director | 07 Apr 2011 | Past |
| Pramod Abcsdd | Additional Director | 22 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Thyrocare Technologies Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.55% decrease. The company also saw a substantial fall in profitability, with a 62.53% decrease in profit. The company's net worth moved up by a moderate rise of 0.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Thyrocare Technologies had a promoter holding of 71.14% and a public holding of 28.86%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹450,462,325.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2023 | Hdfc Bank Limited | ₹45.00 Cr | Satisfied |
| 29 Apr 2002 | Uti Bank Ltd; | ₹0.46 M | Satisfied |
Explore comprehensive loan charge details -
Thyrocare Technologies has a workforce of 1758 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Thyrocare Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thyrocare Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vikram Gupta was appointed as a Cfo was appointed as a Cfo on 21 Aug 2025 & has been associated with this company since 3 months 6 days . was documented.
Progress on Thyrocare Technologies Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records. was documented.
Alok Kumar Jagnani was appointed as a Additional Director was appointed as a Additional Director on 24 Jul 2025 & has been associated with this company since 4 months 4 days . was recorded as a recent event.
Thyrocare Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Brijesh Kumar was appointed as a Company Secretary was appointed as a Company Secretary on 13 Feb 2025 & has been associated with this company since 9 months 12 days . was recorded as a recent event.
Progress on A charge registered on 29 Apr 2023 via Charge ID 100724039 with Hdfc Bank Limited was fully satisfied on 16 Jul 2024. was documented.
The CIN of Thyrocare Technologies Limited is L85110MH2000PLC123882.
Thyrocare Technologies Limited is headquartered at D37/1, Ttc Industrial Area, Midc, Turbhe,, Navi Mumbai, Maharashtra, 400703.
Thyrocare Technologies Limited was incorporated on 28 January 2000.
The current directors of Thyrocare Technologies Limited are
The primary industry of Thyrocare Technologies Limited is Hospital And Medical Care.
Thyrocare Technologies Limited is listed. It is listed on BSE: 539871 and NSE: THYROCARE.
The authorized capital of Thyrocare Technologies Limited is ₹100.00 Cr, and the paid-up capital is ₹53.05 Cr.
The compliance status of Thyrocare Technologies Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX